Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
The summary for the Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS): The Centers for Disease Control/Agency for Toxic Substances and Disease Registry (CDC/ATSDR) is seeking investigator-initiated research that will further the understanding of potential risk factors for Amyotrophic Lateral Sclerosis (ALS), while supporting the National ALS Registry"s mission. The National ALS Registry"s goals are to estimate the number of new ALS cases each year, estimate the number of people who have ALS at a specific point in time, better understand who gets ALS, and identify what contributing factors, including environmental, may affect ALS. CDC/ATSDR is seeking investigator-initiated research that will identify and evaluate risk factors contributing to ALS, with preferred focus in this Notice of Funding Opportunity on factors related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. Research proposals on preferred topics can be funded under one of two funding options, Funding Option A or Funding Option B. Funding Option A is intended to support ALS risk factor research investigations that have an existing, well substantiated evidence base and would benefit from strengthened rigorous evaluation. Funding Option B is intended to support novel ALS risk factor research investigations that may or may not have an existing evidence base foundation base, may be supported by limited and insuffiicient preliminary research, and are exploratory and developmental in nature. Application Type: NEW AMENDMENT to update pre-application teleconference date Special Date(s): A pre-application teleconference call will be conducted on November 7, 2022 to address questions from prospective applicants regarding NOFO RFA-TS-23-001 Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS). The call will begin at 12:00PM Eastern Standard Time (EST) and end at 1:00PM Eastern Standard Time (EST), or sooner if all questions are addressed. Questions and answers from the discussion will be included in an amended NOFO approximately 2 weeks after the call. Participant Access Information: Call Date: November 7, 2022, 12:00 PM Eastern Standard Time (EST) Call End Time: 1:00 PM Eastern Standard Time (EST) Call Leader: Susana Panero, MD, Scientific Program Official Toll-Free Number: 866-600-6035 Use Passcode 23198543# when prompted
Federal Grant Title: | Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) |
Federal Agency Name: | Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-TS-23-001 |
Type of Funding: | Grant |
CFDA Numbers: | 93.061 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | January 5th, 2023 |
Original Application Deadline: | January 5th, 2023 |
Posted Date: | September 30th, 2022 |
Creation Date: | September 30th, 2022 |
Archive Date: | January 20th, 2023 |
Total Program Funding: | $7,500,000 |
Maximum Federal Grant Award: | $500,000 |
Minimum Federal Grant Award: | $0 |
Expected Number of Awards: | 8 |
Cost Sharing or Matching: | No |
Last Updated: | December 21st, 2022 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification.) - Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Additional Information on Eligibility
- See Section III. Eligibility Information.
- Grant Announcement Contact
- Susana Panero, MD
[email protected]
[email protected] - Similar Government Grants
- • PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Re...
- • PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Re...
- • Identify, Analyze, and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (...
- • PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Re...
- • PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Re...
- • Cdc Public Health Research: Health Protection Research Initiative Graduate Training Progra...
- • Improving Public Health Practice through Translation Research (R18)
- • CDC Health Protection Research Initiative: Evaluation of Workplace Health Promotion Resear...
- More Grants from the Centers for Disease Control and Prevention ERA
- • Collaborative research on influenza and other respiratory pathogens in South Africa
- • Advancing Public Health Research in Bangladesh
- • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...
- • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...
- • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...